Pricing Log in Create free account

C4 Therapeutics, Inc. (CCCC) vs Contineum Therapeutics, Inc. (CTNM)

C4 Therapeutics, Inc. and Contineum Therapeutics, Inc. are both Biotechnology companies. C4 Therapeutics, Inc. and Contineum Therapeutics, Inc. are of similar size ($362.9M and $345.9M). Contineum Therapeutics, Inc. has the higher net margin (0.00% vs −282.2%) and the lower return on invested capital (−4,845.6% vs −280.0%). Across the 12 metrics below, Contineum Therapeutics, Inc. leads on 9 and C4 Therapeutics, Inc. on 3.

Valuation

Metric CCCC CTNM Biotechnology median
P/E n/m n/m 10.60
P/S 13.15 n/m 9.40
P/B 1.86 1.47 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 7.38 n/m 9.02
Earnings yield (23.08%) (18.76%) (32.88%)
Free cash flow yield (18.88%) (14.44%) (23.13%)

Profitability

Metric CCCC CTNM Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin (315.86%) 0.00% 0.00%
Net margin (282.22%) 0.00% 0.00%
Free cash flow margin (246.71%) 0.00% 0.00%
Return on equity (47.62%) (29.80%) (51.96%)
Return on assets (30.50%) (28.34%) (46.06%)
Return on invested capital (279.99%) (4,845.62%) 0.00%

Growth

Metric CCCC CTNM Biotechnology median
Revenue growth (TTM) 7.20% — 6.76%
EPS growth (last fiscal year) 16.45% 0.46% 29.88%
Revenue growth, 5-year CAGR 1.61% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CCCC CTNM Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.17 31.11 4.97
Net debt to EBITDA 2.14 3.88 1.01

Dividend

Metric CCCC CTNM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CCCC CTNM Biotechnology median
Market cap 362.93m 345.93m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack